Position in BHVN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$148,342,815
+$132,453,665 QoQ
Shares Held
17,534,612
+1145.9% QoQ
Ownership
11.6%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. BHVN ranks #24 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,541,732 | $1,856,099,791 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
3,458,863 | $1,114,411,067 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,018,647 | $1,056,701,142 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
13,179,013 | $978,673,503 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
16,575,875 | $963,224,094 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,131,527 | $951,812,064 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,766,496 | $949,791,733 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,945,813 | $641,654,204 |
All Filings in BHVN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,739,978 | 8,584,676 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $148,342,815 | 17,534,612 | Shares | Defined | 2026-05-18 | |
| 2026-01-30 | $198,784,919 | 16,803,459 | Shares | Sole | 2026-02-06 | |
| 2025-12-31 | $15,889,150 | 1,407,365 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $101,649,415 | 6,772,113 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $71,305,278 | 5,053,528 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $154,775,023 | 6,438,229 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $260,793,573 | 6,982,425 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $311,132,856 | 6,226,393 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $204,729,783 | 5,898,294 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $312,471,969 | 5,713,512 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $252,577,478 | 5,901,343 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $138,518,360 | 5,325,581 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $127,177,831 | 5,316,799 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $71,847,090 | 5,259,670 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $63,327,651 | 4,562,511 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,084,120 | 500,799 | Shares | Defined | 2023-01-13 | |
| No filing history on record for this holder in this stock. | ||||||